Blood-to-Plasma Scaling in Hepatic Clearance Equations

Why the Reference Matrix Matters

Hepatic clearance equations combine concentrations, flows, and clearances. Each quantity must refer to a compatible matrix. A measured plasma concentration cannot be multiplied by a blood-referenced clearance as though it were a blood concentration: the product would not equal the elimination rate unless the blood-to-plasma ratio happened to be one. The same bookkeeping issue arises when a model uses a plasma unbound fraction where a blood unbound fraction is required.

The key conversion is simple, but it has consequences throughout the calculation: if blood and plasma concentrations differ, their clearances differ numerically when each is defined relative to its own total concentration. The physical elimination rate, however, does not change when we change reference matrices.

Definition: The blood-to-plasma ratio, denoted $R_b$, is the ratio of total drug concentration in whole blood to total drug concentration in plasma at the same time and under specified conditions: $$ R_b=\frac{C_b}{C_p}. $$ Here $C_b$ and $C_p$ are total concentrations in blood and plasma, respectively. A blood-referenced clearance $CL_b$ is defined by elimination rate $=CL_b C_b$; a plasma-referenced clearance $CL_p$ is defined by elimination rate $=CL_p C_p$. Clearances therefore have units of volume per time, but their numerical values depend on the reference concentration.

Converting Total Clearance Between Matrices

Suppose the same elimination rate is described using either blood or plasma concentration. Equating the two definitions gives $CL_b C_b=CL_p C_p$. Substituting $C_b=R_b C_p$ and cancelling $C_p$ gives the conversion:

CL_p=R_b CL_b,\qquad CL_b=\frac{CL_p}{R_b}.

This is a change of reference, not a change in drug elimination. For example, if $R_b$ is greater than one, blood concentration exceeds plasma concentration at the same time. The clearance expressed relative to plasma concentration is then larger than the clearance expressed relative to blood concentration, because a larger clearance is needed to give the same elimination rate from the smaller plasma concentration.

Worked Example: Converting a Measured Blood Clearance

Consider hypothetical data with a blood-referenced hepatic clearance of $18.0\ \text{L/h}$ and a blood-to-plasma ratio of $0.750$. Find the equivalent plasma-referenced clearance.

The conversion requires that the ratio and clearance describe the same drug, conditions, and concentration convention. Using $CL_p=R_b CL_b$:

CL_p=(0.750)(18.0\ \text{L/h})=13.5\ \text{L/h}.

The plasma-referenced clearance is $13.5\ \text{L/h}$. To check the conversion, take a hypothetical plasma concentration of $2.00\ \text{mg/L}$. The corresponding blood concentration is $C_b=(0.750)(2.00)=1.50\ \text{mg/L}$. Both descriptions give the same elimination rate:

CL_p C_p=(13.5)(2.00)=27.0\ \text{mg/h}, \qquad CL_b C_b=(18.0)(1.50)=27.0\ \text{mg/h}.

Thus the two clearance values differ, but the implied rate is identical.

Relating Blood and Plasma Unbound Fractions

The unbound fraction in a matrix is the fraction of its total drug concentration that is unbound in that matrix. Write these fractions as $f_{u,b}$ in blood and $f_{u,p}$ in plasma. If unbound drug has equilibrated between plasma and blood components, the unbound concentrations are equal:

f_{u,b}C_b=f_{u,p}C_p.

Combining this relation with $C_b=R_b C_p$ yields $f_{u,p}=R_b f_{u,b}$, or $f_{u,b}=f_{u,p}/R_b$. This relationship depends on equilibrium of unbound concentrations and on the ratio and fractions being measured under compatible conditions. It should not be imposed automatically when those conditions are not supported.

Key relationship: When unbound concentrations are equal in blood and plasma, $f_{u,b}=f_{u,p}/R_b$. Total concentration scales by $R_b$, while the unbound fraction scales in the opposite direction so that the unbound concentration remains the same.

Worked Example: Converting an Unbound Fraction

Suppose hypothetical measurements give $R_b=1.60$ and $f_{u,p}=0.0800$. Assuming free-concentration equilibrium between blood and plasma, calculate $f_{u,b}$ and check the result using a total concentration.

Apply $f_{u,b}=f_{u,p}/R_b$:

f_{u,b}=\frac{0.0800}{1.60}=0.0500.

For a check, let $C_p=10.0\ \text{mg/L}$. Then $C_b=(1.60)(10.0)=16.0\ \text{mg/L}$. The unbound concentrations are:

f_{u,p}C_p=(0.0800)(10.0)=0.800\ \text{mg/L}, \qquad f_{u,b}C_b=(0.0500)(16.0)=0.800\ \text{mg/L}.

The values agree, as required by the assumed equilibrium. The result does not mean that total concentrations are equal; they are not.

Keeping the Well-Stirred Model Consistent

For a blood-referenced well-stirred liver model, let $Q_h$ be hepatic blood flow and $CL_{\mathrm{int}}$ be intrinsic clearance acting on unbound drug concentration. Under the model assumptions, the well-mixed liver receives blood at concentration $C_{b,\mathrm{in}}$, and metabolism removes drug at rate $f_{u,b}CL_{\mathrm{int}}C_{b,\mathrm{out}}$, where $C_{b,\mathrm{out}}$ is the well-mixed hepatic concentration. Steady-state mass balance equates delivery to outflow plus metabolism. This gives:

Q_h(C_{b,\mathrm{in}}-C_{b,\mathrm{out}}) = f_{u,b}CL_{\mathrm{int}}C_{b,\mathrm{out}}.

Solving for the ratio of output to input and defining hepatic clearance relative to inlet blood concentration gives the standard blood-referenced expression:

CL_{h,b} = Q_h\frac{f_{u,b}CL_{\mathrm{int}}} {Q_h+f_{u,b}CL_{\mathrm{int}}}.

This form uses blood flow, blood unbound fraction, and blood-referenced clearance. The assumptions include a well-mixed liver, steady-state mass balance, constant flow and input concentration for the calculation, and metabolism proportional to unbound concentration with the specified intrinsic clearance. It does not assert that every liver is physically well mixed; it is a model choice.

If the output is to be expressed relative to plasma concentration, first convert the clearance: $CL_{h,p}=R_b CL_{h,b}$. Under the free-concentration equilibrium relation, this can also be written:

CL_{h,p} = \frac{Q_h f_{u,p}CL_{\mathrm{int}}} {Q_h+(f_{u,p}/R_b)CL_{\mathrm{int}}}.

The denominator still contains $f_{u,b}CL_{\mathrm{int}}$, expressed here as $(f_{u,p}/R_b)CL_{\mathrm{int}}$. Replacing it with $f_{u,p}CL_{\mathrm{int}}$ while retaining blood flow would not be the same model: it would silently substitute a different unbound fraction without changing the rest of the reference framework.

Worked Example: Quantifying a Mixed-Matrix Error

Consider hypothetical values $Q_h=90.0\ \text{L/h}$, $CL_{\mathrm{int}}=300\ \text{L/h}$, $f_{u,p}=0.100$, and $R_b=2.00$. Assume free-concentration equilibrium, so $f_{u,b}=0.100/2.00=0.0500$. Calculate the well-stirred clearance in both reference matrices, then quantify the error from using $f_{u,p}$ in the blood-referenced formula.

Using the correct blood fraction:

CL_{h,b} = 90.0\frac{(0.0500)(300)}{90.0+(0.0500)(300)} = 90.0\frac{15.0}{105} = 12.9\ \text{L/h}.

Convert to plasma reference using the same ratio:

CL_{h,p}=R_b CL_{h,b}=(2.00)(12.857)=25.7\ \text{L/h}.

Now consider the incorrect calculation that inserts $f_{u,p}=0.100$ into the blood-referenced formula:

CL_{h,b,\mathrm{wrong}} = 90.0\frac{(0.100)(300)}{90.0+(0.100)(300)} = 90.0\frac{30.0}{120} = 22.5\ \text{L/h}.

That value is $9.64\ \text{L/h}$ above the correct blood-referenced result, or $(22.5-12.857)/12.857\times100=75.0\%$ higher. The error arises because the blood model requires $f_{u,b}$, not $f_{u,p}$. The incorrectly calculated value cannot be repaired by describing it as plasma clearance; the reference matrix must be transformed consistently throughout the calculation.

Assumptions, Diagnostics, and Alternatives

A single $R_b$ is useful only when it represents the conditions relevant to the clearance calculation. Check that the ratio is based on compatible sampling times, concentrations, species, and experimental conditions. If the ratio changes with concentration or time, a single constant conversion may be inadequate. Also check whether reported clearance is referenced to plasma or blood; the label or method definition is more informative than the word “clearance” alone.

A practical diagnostic is to calculate the elimination rate in both reference systems for a chosen concentration pair. The results should agree:

$$ CL_b C_b=CL_p C_p. $$

A failure of this identity usually indicates a conversion or unit error, an inconsistent $R_b$, or quantities that do not refer to the same conditions. For unbound fractions, check that $f_{u,b}C_b$ and $f_{u,p}C_p$ agree if free-concentration equilibrium is being assumed. A disagreement means the assumption and inputs cannot all be true simultaneously.

The main alternative to applying an explicit blood-to-plasma conversion is to formulate the entire calculation in one matrix from the outset. For example, a blood-based calculation uses blood concentration, blood clearance, blood flow, and $f_{u,b}$; a plasma-based calculation must transform clearance and unbound fraction consistently and retain the correct flow and concentration relationships. Directly using measured blood concentrations can be preferable when blood is the matrix relevant to hepatic delivery and reliable measurements are available. Conversely, plasma-based reporting may be required for comparison with plasma observations, but it does not remove the need to document the conversion assumptions.

The introductory material on unbound-fraction effects in hepatic clearance models establishes why free concentration matters to the well-stirred expression. The additional issue here is matrix bookkeeping: a correct unbound-fraction effect can still yield a wrong prediction if $f_{u,p}$, $f_{u,b}$, $C_p$, $C_b$, and clearance are mixed without conversion.

Common Pitfall and Practical Consequences

Wrong reasoning: “Clearance is a property of the drug, so its numerical value is unchanged whether I use blood or plasma concentration.”
Correction: The elimination process is unchanged, but clearance is defined as rate divided by a specified concentration. Because $C_b$ and $C_p$ can differ, $CL_b$ and $CL_p$ generally differ by the factor $R_b$.
Wrong reasoning: “The plasma unbound fraction can be used in a blood-based liver equation because both fractions describe the same drug.”
Correction: Under free-concentration equilibrium, $f_{u,b}=f_{u,p}/R_b$. Use the fraction corresponding to the total concentration in the model equation.
Wrong reasoning: “A ratio measured in one setting is automatically valid in every PBPK application.”
Correction: The conversion is only as appropriate as the ratio and equilibrium assumptions. Species, concentration range, sampling conditions, or binding behavior may limit transfer.

In PBPK applications, inconsistent matrix choices can affect more than a reported clearance. They can alter the balance between hepatic flow and metabolic capacity in the model, leading to systematically different predictions. Recording the reference matrix alongside each input, and checking rate invariance after conversion, is a simple but important quality-control step.

Check Your Understanding

Answer each question, then compare your reasoning with the brief solutions.

If $R_b=0.800$ and $CL_b=25.0\ \text{L/h}$, what is $CL_p$?
Under free-concentration equilibrium, $R_b=1.25$ and $f_{u,p}=0.0500$. What is $f_{u,b}$?
Why must $CL_bC_b$ and $CL_pC_p$ be equal when both clearances describe the same elimination rate?
A model uses hepatic blood flow and blood concentration. Which unbound fraction belongs in its blood-referenced well-stirred expression, and what assumption connects it to $f_{u,p}$?
If $R_b$ varies over the concentration range of interest, what is the main risk of using one constant conversion factor?

Solutions. (1) $CL_p=R_bCL_b=(0.800)(25.0)=20.0\ \text{L/h}$. (2) $f_{u,b}=f_{u,p}/R_b=0.0500/1.25=0.0400$. (3) Each product is the same physical elimination rate expressed using a different reference concentration, so equality follows from the definitions of the two clearances. (4) Use $f_{u,b}$; the relation $f_{u,b}=f_{u,p}/R_b$ requires equal unbound concentrations in blood and plasma. (5) A constant $R_b$ may mis-scale concentrations, clearances, and derived fractions at some concentrations, so the resulting predictions may not represent the conditions being modeled.